Albert E. Hallsworth
15 Cotswold Road, Surrey
Sutton Upon Derwent, ENG SM25NG, United Kingdom
Sutton Upon Derwent, ENG SM25NG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imaging.
Journal: Neoplasia (New York, N.Y.)
Published: September 14, 2024
Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 In Vivo.
Journal: Journal of medicinal chemistry
Published: June 02, 2022
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage.
Journal: Nature communications
Published: October 06, 2020
Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice.
Journal: Scientific reports
Published: January 14, 2020
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma.
Journal: The Journal of clinical investigation
Published: October 08, 2019
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma.
Journal: Oncotarget
Published: September 24, 2019
Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform.
Journal: British journal of cancer
Published: May 30, 2017
p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.
Journal: Cancer research
Published: July 20, 2015
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 08, 2015
Last Updated: 09/26/2026